These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 11272899)
21. PIK3CA-AKT pathway mutations in micropapillary breast carcinoma. Flatley E; Ang D; Warrick A; Beadling C; Corless CL; Troxell ML Hum Pathol; 2013 Jul; 44(7):1320-7. PubMed ID: 23352210 [TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity and allelic imbalance in apocrine adenosis of the breast. Selim AG; Ryan A; El-Ayat GA; Wells CA Cancer Detect Prev; 2001; 25(3):262-7. PubMed ID: 11425268 [TBL] [Abstract][Full Text] [Related]
23. Endostatin gene variation and protein levels in breast cancer susceptibility and severity. Balasubramanian SP; Cross SS; Globe J; Cox A; Brown NJ; Reed MW BMC Cancer; 2007 Jun; 7():107. PubMed ID: 17587451 [TBL] [Abstract][Full Text] [Related]
24. Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysis. Gjerdrum LM; Sorensen BS; Kjeldsen E; Sorensen FB; Nexo E; Hamilton-Dutoit S J Mol Diagn; 2004 Feb; 6(1):42-51. PubMed ID: 14736826 [TBL] [Abstract][Full Text] [Related]
25. Clonality analysis of defined cell populations in paraffin-embedded tissue sections by RT-PCR amplification of X-linked G6PD gene. Peng H; R Lakhani S; Lee C; Zheng Q; Chaggar RK; Wright NA; Pan L; Isaacson PG J Pathol; 2000 Jul; 191(3):313-7. PubMed ID: 10878554 [TBL] [Abstract][Full Text] [Related]
26. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias. Done SJ; Arneson NC; Ozçelik H; Redston M; Andrulis IL Cancer Res; 1998 Feb; 58(4):785-9. PubMed ID: 9485035 [TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor mRNA levels quantified by reverse transcription-polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components. Yamasaki T; Tsuda H; Imazeki N; Matsubara O Pathol Int; 2005 May; 55(5):255-63. PubMed ID: 15871723 [TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer. Yaremko ML; Kutza C; Lyzak J; Mick R; Recant WM; Westbrook CA Genes Chromosomes Cancer; 1996 Jul; 16(3):189-95. PubMed ID: 8814452 [TBL] [Abstract][Full Text] [Related]
29. Detection and quantification of microRNAs in laser-microdissected formalin-fixed paraffin-embedded breast cancer tissues. Khoshnaw SM; Powe DG; Ellis IO; Green AR Methods Mol Biol; 2011; 755():119-42. PubMed ID: 21761299 [TBL] [Abstract][Full Text] [Related]
30. New approaches for genotyping paraffin wax embedded breast tissue from patients with cancer: the Iowa women's health study. Thyagarajan B; Anderson KE; Kong F; Selk FR; Lynch CF; Gross MD J Clin Pathol; 2005 Sep; 58(9):955-61. PubMed ID: 16126877 [TBL] [Abstract][Full Text] [Related]
31. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors. Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193 [TBL] [Abstract][Full Text] [Related]
32. Clonal analysis of predominantly intraductal carcinoma and precancerous lesions of the breast by means of polymerase chain reaction. Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H Cancer Res; 1994 Apr; 54(7):1849-53. PubMed ID: 7907946 [TBL] [Abstract][Full Text] [Related]
33. PCR artifacts in LOH and MSI analysis of microdissected tumor cells. Sieben NL; ter Haar NT; Cornelisse CJ; Fleuren GJ; Cleton-Jansen AM Hum Pathol; 2000 Nov; 31(11):1414-9. PubMed ID: 11112218 [TBL] [Abstract][Full Text] [Related]
34. Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lakhani SR; Slack DN; Hamoudi RA; Collins N; Stratton MR; Sloane JP Lab Invest; 1996 Jan; 74(1):129-35. PubMed ID: 8569175 [TBL] [Abstract][Full Text] [Related]
35. Whole genome amplification and molecular genetic analysis of DNA from paraffin-embedded prostate adenocarcinoma tumor tissue. Kim SH; Godfrey T; Jensen RH J Urol; 1999 Oct; 162(4):1512-8. PubMed ID: 10492247 [TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity in ductal carcinoma in situ of the breast. Stratton MR; Collins N; Lakhani SR; Sloane JP J Pathol; 1995 Feb; 175(2):195-201. PubMed ID: 7738715 [TBL] [Abstract][Full Text] [Related]
37. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival. Marsh JW; Finkelstein SD; Demetris AJ; Swalsky PA; Sasatomi E; Bandos A; Subotin M; Dvorchik I Liver Transpl; 2003 Jul; 9(7):664-71. PubMed ID: 12827550 [TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer. Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281 [TBL] [Abstract][Full Text] [Related]
39. Multiplex loss of heterozygosity analysis by using single or very few cells. Cui X; Feiner H; Li H J Mol Diagn; 2002 Aug; 4(3):172-7. PubMed ID: 12169679 [TBL] [Abstract][Full Text] [Related]
40. Allelic loss of chromosomal arm 8p in breast cancer progression. Anbazhagan R; Fujii H; Gabrielson E Am J Pathol; 1998 Mar; 152(3):815-9. PubMed ID: 9502423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]